Mersana Therapeutics logo

Mersana Therapeutics

MRSN | NASDAQ
Chart Builder DCF Calculator
$29.08
$0.00 (0.00%)
At close: Jan 5, 2026, 3:55 PM ET
+0.00%

Rating

Updated: Sep 29, 2026
39.2
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $145.36M
1D Range
28.78 29.08
52W Range
5.21 30.39

Valuation (TTM)

PE -2.06
PB -2.44
EV/EBITDA -1.38

Valuation (NTM)

Forward PE N/A
Forward PEG -0.13
Price Target $10.00
Loading financial charts...

Profile

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering novel antibody-drug conjugates (ADCs) for cancer patients with pressing unmet medical needs. Their flag...

Sector Healthcare
Industry Biotechnology
Employees 102
IPO Date Jun 28, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$10.00
Downside
-65.61%
Buy (0)
Hold (3)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.